Compare GIB & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIB | RVTY |
|---|---|---|
| Founded | 1976 | 1937 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 11.6B |
| IPO Year | 1999 | 1994 |
| Metric | GIB | RVTY |
|---|---|---|
| Price | $62.19 | $113.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 16 |
| Target Price | ★ $112.00 | $109.67 |
| AVG Volume (30 Days) | 418.6K | ★ 1.4M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.70% | 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $8.33 | $6.37 |
| Revenue Next Year | $2.96 | $5.10 |
| P/E Ratio | ★ $13.59 | $294.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $59.63 | $81.22 |
| 52 Week High | $106.68 | $118.30 |
| Indicator | GIB | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 37.64 | 69.85 |
| Support Level | $61.35 | $90.57 |
| Resistance Level | $70.68 | $118.30 |
| Average True Range (ATR) | 1.95 | 4.02 |
| MACD | -0.42 | 0.62 |
| Stochastic Oscillator | 29.02 | 93.35 |
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.